SCHEMBL5376322

SCHEMBL5376322

NC(=O)c1ccc2cc(N3CCC(Cc4ccccc4)CC3)[nH]c2c1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.51
GAA P10253 2/20 0.46
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
GRIN2D O15399 3/20 0.45
GRIN3B O60391 3/20 0.45
GRIN1 Q05586 3/20 0.45
GRIN2A Q12879 3/20 0.45
GRIN2B Q13224 3/20 0.45
GRIN2C Q14957 3/20 0.45
GRIN3A Q8TCU5 3/20 0.45
HTR2B P41595 1/20 0.44
MAPK14 Q16539 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5383885 0.84 GPR84 (0.51) GPR84GAACYP2C9CYP2C19ALDH1A1
SCHEMBL5374207 0.82 GPR84 (0.52) GPR84GAACYP2C9CYP2C19ALDH1A1
SCHEMBL5387265 0.82 GPR84 (0.52) GPR84GAACYP2C9CYP2C19ALDH1A1
SCHEMBL5733660 0.78 GAA (0.54) GPR84GAACYP2C9CYP2C19ALDH1A1
SCHEMBL5203581 0.76 GAA (0.54) GPR84GAACYP2C9CYP2C19ALDH1A1
SCHEMBL5201673 0.75 MEN1 (0.59) GPR84CYP2C9CYP2C19MAPK14MEN1
SCHEMBL5378331 0.74 GRIN1 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5365951 0.73 MEN1 (0.52) GPR84GAACYP2C9CYP2C19ALDH1A1
SCHEMBL5376292 0.73 MAPK14 (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5377680 0.72 CYP2C9 (0.45) GPR84GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed